Susquehanna International Group
ARRY

Susquehanna International Group’s Array Biopharma Inc ARRY Stock Holding History

Susquehanna International Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-581,140
Closed -$26.9M – 11269
2019
Q2 		$26.9M Buy
+581,140
New +$16.3M 0.01% 1080
2018
Q3 		– Sell
-306,944
Closed -$4.7M – 10752
2018
Q2 		$5.15M Buy
+306,944
New +$4.88M ﹤0.01% 2670
2018
Q1 		– Sell
-520,780
Closed -$8.34M – 10667
2017
Q4 		$6.67M Sell
520,780
-118,774
-19% -$1.35M ﹤0.01% 2209
2017
Q3 		$7.87M Buy
639,554
+283,202
+79% +$2.63M ﹤0.01% 2001
2017
Q2 		$2.98M Buy
356,352
+203,917
+134% +$1.67M ﹤0.01% 3152
2017
Q1 		$1.36M Sell
152,435
-274,906
-64% -$2.92M ﹤0.01% 4478
2016
Q4 		$3.76M Buy
427,341
+396,861
+1,302% +$2.92M ﹤0.01% 2882
2016
Q3 		$206K Sell
30,480
-307,930
-91% -$1.19M ﹤0.01% 7544
2016
Q2 		$1.21M Buy
+338,410
New +$1.1M ﹤0.01% 4489
2016
Q1 		– Sell
-35,158
Closed -$105K – 10020
2015
Q4 		$149K Sell
35,158
-190,148
-84% -$868K ﹤0.01% 8654
2015
Q3 		$1.03M Buy
225,306
+180,531
+403% +$1.07M ﹤0.01% 5692
2015
Q2 		$323K Buy
44,775
+19,757
+79% +$146K ﹤0.01% 8410
2015
Q1 		$184K Sell
25,018
-551,770
-96% -$3.93M ﹤0.01% 8686
2014
Q4 		$2.73M Buy
576,788
+363,333
+170% +$1.44M ﹤0.01% 3892
2014
Q3 		$762K Buy
213,455
+4,739
+2% +$18.7K ﹤0.01% 6453
2014
Q2 		$952K Sell
208,716
-362,240
-63% -$1.5M ﹤0.01% 6147
2014
Q1 		$2.68M Buy
570,956
+74,742
+15% +$376K ﹤0.01% 3828
2013
Q4 		$2.49M Buy
496,214
+364,438
+277% +$1.98M ﹤0.01% 3926
2013
Q3 		$819K Buy
131,776
+51,419
+64% +$305K ﹤0.01% 5647
2013
Q2 		$365K Buy
+80,357
New +$432K ﹤0.01% 6508

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Susquehanna International Group's ARRY Position: Q3 2019 in Review

Susquehanna International Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 581,140 shares — an estimated $26.9M sold.

Susquehanna International Group first reported a position in ARRY in Q2 2013 and held it in 20 quarters. The position peaked at $26.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Susquehanna International Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Susquehanna International Group sold 581,140 Array Biopharma Inc shares in Q3 2019, an estimated $26.9M.
  • Susquehanna International Group first reported a position in Array Biopharma Inc in Q2 2013 and held it in 20 quarters.
  • Susquehanna International Group's Array Biopharma Inc position peaked at $26.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.